See more : Shanthi Gears Limited (SHANTIGEAR.BO) Income Statement Analysis – Financial Results
Complete financial analysis of AIkido Pharma Inc. (AIKI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AIkido Pharma Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Vext Science, Inc. (VEXTF) Income Statement Analysis – Financial Results
- Wm Morrison Supermarkets PLC (MRW.L) Income Statement Analysis – Financial Results
- Equitable Holdings, Inc. (EQH-PA) Income Statement Analysis – Financial Results
- Divgi TorqTransfer Systems Limited (DIVGIITTS.BO) Income Statement Analysis – Financial Results
- Beijing New Building Materials Public Limited Company (000786.SZ) Income Statement Analysis – Financial Results
AIkido Pharma Inc. (AIKI)
About AIkido Pharma Inc.
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 9.00K | 28.00K | 1.24M | 877.00K | 33.00K | 10.00K | 27.00K | 19.92K | 820.93K | 1.43M | 1.36M | 1.03M | 154.70K | 24.84M | 23.05M | 22.35M | 18.09M | 15.13M | 19.94M | 17.03M | 12.70M | 16.00M | 13.60M | 13.80M | 13.70M | 16.00M | 13.60M | 16.70M | 15.10M | 15.90M | 15.30M | 13.60M | 10.50M | 8.00M | 6.70M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 81.00K | 92.00K | 84.00K | 88.00K | 864.00K | 3.00K | 0.00 | 388.07K | 517.68K | 449.29K | 397.65K | 54.29K | 20.79M | 17.93M | 17.36M | 12.60M | 11.55M | 13.64M | 11.09M | 9.60M | 12.50M | 9.90M | 9.60M | 9.90M | 12.90M | 10.40M | 13.20M | 12.40M | 13.30M | 12.90M | 11.10M | 7.70M | 5.90M | 5.20M |
Gross Profit | 0.00 | 0.00 | 0.00 | 9.00K | -53.00K | 1.14M | 793.00K | -55.00K | -854.00K | 24.00K | 19.92K | 432.86K | 914.78K | 909.82K | 628.32K | 100.41K | 4.04M | 5.12M | 4.99M | 5.48M | 3.58M | 6.30M | 5.95M | 3.10M | 3.50M | 3.70M | 4.20M | 3.80M | 3.10M | 3.20M | 3.50M | 2.70M | 2.60M | 2.40M | 2.50M | 2.80M | 2.10M | 1.50M |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 100.00% | -189.29% | 92.56% | 90.42% | -166.67% | -8,540.00% | 88.89% | 100.00% | 52.73% | 63.86% | 66.94% | 61.24% | 64.90% | 16.28% | 22.21% | 22.31% | 30.32% | 23.66% | 31.59% | 34.91% | 24.41% | 21.88% | 27.21% | 30.43% | 27.74% | 19.38% | 23.53% | 20.96% | 17.88% | 16.35% | 15.69% | 18.38% | 26.67% | 26.25% | 22.39% |
Research & Development | 830.00K | 559.00K | 2.49M | 2.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.00K | 727.09K | 1.65M | 4.85M | 6.83M | 4.00M | 5.87M | 883.61K | 288.11K | 196.36K | 423.17K | 476.00K | 390.16K | 281.08K | 300.00K | 400.00K | 600.00K | 600.00K | 500.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 11.68M | 7.73M | 4.06M | 0.00 | 3.06M | 3.69M | 4.58M | 5.13M | 20.79M | 15.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 11.68M | 7.73M | 4.06M | 3.17M | 3.06M | 3.69M | 4.58M | 5.13M | 20.79M | 15.07M | 2.76M | 3.13M | 4.08M | 3.27M | 3.14M | 3.87M | 5.64M | 5.14M | 5.36M | 5.83M | 4.51M | 4.03M | 3.94M | 3.70M | 3.80M | 2.80M | 2.50M | 2.30M | 2.70M | 2.00M | 1.90M | 2.10M | 2.30M | 2.30M | 1.60M | 1.30M | 1.20M | 1.10M |
Other Expenses | 1.83M | 1.15M | 1.47M | 0.00 | 1.44M | 1.37M | 2.14M | 6.32M | 9.83M | 291.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.57M | 2.28M | 1.50M | 1.59M | 1.42M | 1.31M | 1.70M | 1.30M | 600.00K | 700.00K | 500.00K | 400.00K | 500.00K | 600.00K | 600.00K | 600.00K | 500.00K | 500.00K | 400.00K | 300.00K | 200.00K |
Operating Expenses | 14.35M | 9.44M | 6.55M | 5.69M | 4.50M | 5.06M | 6.72M | 11.44M | 30.62M | 15.37M | 3.49M | 4.78M | 8.93M | 10.10M | 7.14M | 9.74M | 6.52M | 8.00M | 7.83M | 7.76M | 6.58M | 5.84M | 5.54M | 5.70M | 5.50M | 4.00M | 3.80M | 3.30M | 3.10M | 2.50M | 2.50M | 2.70M | 2.90M | 2.80M | 2.10M | 1.70M | 1.50M | 1.30M |
Cost & Expenses | 14.35M | 9.44M | 6.55M | 5.69M | 4.50M | 5.06M | 6.72M | 11.44M | 30.62M | 15.37M | 3.49M | 5.17M | 9.44M | 10.55M | 7.54M | 9.79M | 27.32M | 25.93M | 25.19M | 20.36M | 18.13M | 19.48M | 16.62M | 15.30M | 18.00M | 13.90M | 13.40M | 13.20M | 16.00M | 12.90M | 15.70M | 15.10M | 16.20M | 15.70M | 13.20M | 9.40M | 7.40M | 6.50M |
Interest Income | 687.00K | 252.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.46K | 6.11K | 37.65K | 348.44K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 7.76M | -2.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.00K | 2.22K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | -188.00K | 2.27M | -5.79M | 1.50M | 1.44M | 1.38M | 2.14M | 6.32M | 9.83M | 291.00K | 63.68K | 69.83K | 77.87K | 84.38K | 85.72K | 210.42K | 2.60M | 2.57M | 2.28M | 1.50M | 1.59M | 1.42M | 1.31M | 1.70M | 1.30M | 600.00K | 700.00K | 500.00K | 400.00K | 500.00K | 600.00K | 600.00K | 600.00K | 500.00K | 500.00K | 400.00K | 300.00K | 200.00K |
EBITDA | -14.35M | -7.17M | -12.34M | -4.18M | 3.17M | -1.93M | -4.34M | -45.15M | -20.70M | -17.67M | -3.79M | -3.38M | -7.79M | -9.06M | -4.60M | -4.14M | 6.22M | -274.50K | -544.36K | -753.77K | -1.33M | 1.99M | 1.91M | -3.20M | -800.00K | 400.00K | 900.00K | 1.00M | 400.00K | -100.00K | 1.70M | 800.00K | 300.00K | 100.00K | 800.00K | 1.30M | 800.00K | 300.00K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | -46,477.78% | 11,321.43% | -156.15% | -494.64% | -136,809.09% | -207,010.00% | -65,459.26% | -19,041.00% | -411.41% | -543.93% | -666.93% | -448.40% | -2,673.58% | 25.04% | -1.19% | -2.44% | -4.17% | -8.78% | 9.99% | 11.19% | -25.20% | -5.00% | 2.94% | 6.52% | 7.30% | 2.50% | -0.74% | 10.18% | 5.30% | 1.89% | 0.65% | 5.88% | 12.38% | 10.00% | 4.48% |
Operating Income | -14.35M | -9.44M | -6.55M | -5.69M | -6.87M | -3.82M | -8.55M | -52.01M | -30.61M | -15.35M | -3.47M | -4.35M | -8.01M | -9.19M | -6.51M | -9.64M | -2.48M | -2.89M | -2.85M | -2.27M | -3.00M | 453.77K | 411.05K | -2.60M | -2.00M | -300.00K | 400.00K | 500.00K | 0.00 | 700.00K | 1.00M | 200.00K | -300.00K | -400.00K | 400.00K | 1.10M | 600.00K | 200.00K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | -63,166.67% | -24,550.00% | -309.22% | -975.03% | -157,606.06% | -306,110.00% | -56,840.74% | -17,427.99% | -529.51% | -559.28% | -675.90% | -634.68% | -6,229.60% | -9.98% | -12.52% | -12.73% | -12.58% | -19.85% | 2.28% | 2.41% | -20.47% | -12.50% | -2.21% | 2.90% | 3.65% | 0.00% | 5.15% | 5.99% | 1.32% | -1.89% | -2.61% | 2.94% | 10.48% | 7.50% | 2.99% |
Total Other Income/Expenses | -7.76M | 2.27M | -5.79M | 1.50M | 8.60M | 516.00K | 2.08M | 545.00K | 79.00K | -2.62M | 583.97K | 899.72K | 142.02K | 37.65K | 340.23K | 377.98K | 6.10M | 37.15K | 23.45K | 17.88K | 81.07K | 114.06K | 0.00 | -2.30M | -100.00K | 100.00K | -200.00K | 0.00 | 0.00 | -100.00K | 100.00K | 0.00 | -300.00K | -100.00K | -100.00K | -200.00K | -100.00K | 0.00 |
Income Before Tax | -22.11M | -7.17M | -12.34M | -4.18M | 1.73M | -3.31M | -6.48M | -51.47M | -30.53M | -17.97M | -2.89M | -3.45M | -7.87M | -9.15M | -6.17M | -9.26M | 3.62M | -2.85M | -2.82M | -2.26M | -2.92M | 567.82K | 0.00 | -4.90M | -2.10M | -200.00K | 200.00K | 500.00K | 0.00 | 600.00K | 1.10M | 200.00K | -600.00K | -500.00K | 300.00K | 900.00K | 500.00K | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -46,477.78% | 6,167.86% | -267.48% | -738.43% | -155,954.55% | -305,320.00% | -66,537.04% | -14,496.70% | -419.91% | -549.37% | -673.13% | -601.52% | -5,985.26% | 14.57% | -12.36% | -12.63% | -12.48% | -19.31% | 2.85% | 0.00% | -38.58% | -13.13% | -1.47% | 1.45% | 3.65% | 0.00% | 4.41% | 6.59% | 1.32% | -3.77% | -3.27% | 2.21% | 8.57% | 6.25% | 0.00% |
Income Tax Expense | 7.76M | -2.27M | 0.00 | 0.00 | 8.60M | 516.00K | 2.08M | 545.00K | 79.00K | -2.62M | 583.97K | 14.49K | -133.19K | 37.65K | -552.80K | -3.41M | 105.05K | 37.15K | 23.45K | 17.88K | 81.12K | 114.06K | 0.00 | 300.00K | -100.00K | -100.00K | 100.00K | 100.00K | 100.00K | 200.00K | 400.00K | 100.00K | -200.00K | -200.00K | 100.00K | 400.00K | 200.00K | 0.00 |
Net Income | -29.87M | -4.90M | -12.34M | -4.18M | 1.73M | -3.31M | -6.48M | -51.47M | -30.53M | -17.97M | -3.86M | -3.46M | -7.74M | -9.15M | -4.14M | -938.37K | 3.51M | -2.85M | -2.82M | -2.26M | -2.92M | 567.82K | 591.07K | -5.20M | -2.00M | -100.00K | 100.00K | 400.00K | -100.00K | -800.00K | 700.00K | 100.00K | -400.00K | -300.00K | 200.00K | 500.00K | 300.00K | 100.00K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | -46,477.78% | 6,167.86% | -267.48% | -738.43% | -155,954.55% | -305,320.00% | -66,537.04% | -19,360.63% | -421.68% | -540.07% | -673.13% | -403.09% | -606.58% | 14.14% | -12.36% | -12.63% | -12.48% | -19.31% | 2.85% | 3.47% | -40.94% | -12.50% | -0.74% | 0.72% | 2.92% | -0.63% | -5.88% | 4.19% | 0.66% | -2.52% | -1.96% | 1.47% | 4.76% | 3.75% | 1.49% |
EPS | -5.60 | -2.97 | -7.47 | -28.31 | 15.48 | -43.13 | -126.45 | -2.20K | -2.12K | -18.73K | -19.38K | -36.06K | -117.22K | -147.56K | -79.53K | -18.05K | 70.26K | -63.31K | -64.14K | -53.73K | -71.27K | 14.56K | 15.16K | -148.57K | -60.61K | -3.13K | 3.45K | 13.79K | -3.57K | -28.57K | 25.00K | 3.57K | -14.29K | -10.71K | 7.14K | 17.86K | 10.71K | 3.57K |
EPS Diluted | -5.60 | -2.97 | -7.47 | -28.31 | 15.48 | -43.13 | -121.90 | -2.20K | -2.12K | -18.73K | -19.38K | -36.06K | -117.22K | -147.56K | -79.53K | -18.05K | 70.26K | -63.31K | -64.14K | -53.73K | -71.27K | 14.56K | 15.16K | -148.57K | -60.61K | -3.13K | 3.45K | 13.79K | -3.57K | -28.57K | 25.00K | 3.57K | -14.29K | -10.71K | 7.14K | 17.86K | 10.71K | 3.57K |
Weighted Avg Shares Out | 5.33M | 1.65M | 1.65M | 147.74K | 111.57K | 76.66K | 51.21K | 23.44K | 14.38K | 959.00 | 199.00 | 96.00 | 66.00 | 62.00 | 52.00 | 52.00 | 50.00 | 45.00 | 44.00 | 42.00 | 41.00 | 39.00 | 39.00 | 35.00 | 33.00 | 32.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 |
Weighted Avg Shares Out (Dil) | 5.33M | 1.65M | 1.65M | 147.74K | 111.57K | 76.66K | 53.13K | 23.44K | 14.38K | 959.00 | 199.00 | 96.00 | 66.00 | 62.00 | 52.00 | 52.00 | 50.00 | 45.00 | 44.00 | 42.00 | 41.00 | 39.00 | 39.00 | 35.00 | 33.00 | 32.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 |
Bull Flag Pattern: What It Is and Trading Strategies for 2020
Spherix stock soars after option executed for technology in patent for methods to treat coronavirus infection
Source: https://incomestatements.info
Category: Stock Reports